Interest in peptides has grown rapidly as researchers explore how short chains of amino acids may influence signaling throughout the body. One peptide that has attracted particular attention in the areas of cognition, neurological function, and neuroprotection is Semax. Semax is unusual because it has a longer history of clinical investigation than many peptides currently […]
Continue Reading
Interest in peptides has expanded dramatically as researchers investigate how short chains of amino acids may influence everything from metabolism and immune signaling to neurological function. Among peptides being studied for their effects on the brain, Selank has attracted particular attention because of research involving anxiety, stress, cognition, memory, and neurological signaling. Selank is especially […]
Continue Reading
Few experimental metabolic peptides have generated as much attention as retatrutide. Developed by Eli Lilly and Company under the research designation LY3437943, retatrutide is being investigated primarily for obesity and related metabolic conditions. The excitement surrounding retatrutide comes from its unusual mechanism of action. While semaglutide targets the GLP-1 receptor and tirzepatide targets both the […]
Continue Reading
Among the growing number of experimental compounds being investigated for metabolism, body composition, and healthy aging, 5-Amino-1MQ has generated considerable interest. Often discussed alongside research peptides, 5-Amino-1MQ is associated primarily with research involving fat metabolism, obesity, cellular energy, NAD+ biology, and metabolic health. Its mechanism is very different from familiar metabolic compounds such as semaglutide, […]
Continue Reading
AOD-9604 is an experimental peptide that has attracted attention for more than two decades because of its potential effects on fat metabolism, lipolysis, body composition, and obesity research. Unlike many newer metabolic peptides that act through GLP-1, GIP, or glucagon receptors, AOD-9604 originated from research involving human growth hormone, or hGH. Scientists were interested in […]
Continue Reading
Few experimental peptides have developed as much attention within sports medicine, recovery, and regenerative research communities as BPC-157. BPC-157 is most commonly discussed in connection with tendon and ligament healing, muscle recovery, wound repair, gastrointestinal protection, inflammation, and recovery from musculoskeletal injuries. It has become particularly well known among athletes and fitness communities, where it […]
Continue Reading
Cagrilintide is one of the more interesting investigational peptides currently being developed for obesity, appetite regulation, weight management, and metabolic health. Unlike semaglutide, tirzepatide, and retatrutide, cagrilintide is not primarily a GLP-1-based compound. Instead, it is a long-acting amylin analogue, meaning it is designed to mimic and enhance some of the biological effects of the […]
Continue Reading
CJC-1295 without DAC is a synthetic peptide commonly discussed in connection with growth hormone release, recovery, sleep, body composition, muscle preservation, fat metabolism, and healthy-aging research. It belongs to a class of compounds known as growth hormone-releasing hormone analogues, or GHRH analogues. Rather than supplying growth hormone directly, these compounds are designed to stimulate the […]
Continue Reading
CJC-1295 with DAC is a synthetic peptide designed to stimulate the body’s own production of growth hormone, or GH, and indirectly increase insulin-like growth factor 1, or IGF-1. It is commonly discussed in connection with research involving growth hormone secretion, recovery, body composition, muscle preservation, fat metabolism, sleep, healthy aging, and growth hormone deficiency. Unlike […]
Continue Reading
The combination of CJC-1295 and ipamorelin is frequently discussed in peptide research, fitness, recovery, and healthy-aging communities because both compounds influence the body’s growth hormone–IGF-1 axis, but they do so through different receptors. The underlying idea is relatively straightforward. CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, or GHRH. It stimulates GHRH receptors in […]
Continue Reading
